This is obtained by forcibly making them express genes and factors of embryonic stem cells. The first human iPSCs were developed in 2007. Pluripotent stem cells have already been useful for drug development and to imitate diseases. Scientists hope to use them is transplantation medicine. Viruses are used initiate the reprogramming in adult cells. This technique is still under testing so that it can eventually be used in treatment for humans. In the animal studies, the viruses used have been known to cause cancers. Now, cells can be manipulated into roles other than their pre-determined developmental fates. Another advantage is that tissues derived from iPSCs will be an almost identical match to the cell donor, being less likely to be rejected by the immune
This is obtained by forcibly making them express genes and factors of embryonic stem cells. The first human iPSCs were developed in 2007. Pluripotent stem cells have already been useful for drug development and to imitate diseases. Scientists hope to use them is transplantation medicine. Viruses are used initiate the reprogramming in adult cells. This technique is still under testing so that it can eventually be used in treatment for humans. In the animal studies, the viruses used have been known to cause cancers. Now, cells can be manipulated into roles other than their pre-determined developmental fates. Another advantage is that tissues derived from iPSCs will be an almost identical match to the cell donor, being less likely to be rejected by the immune